Revisiting the public health implications of the United States–Mexico– Canada agreement

This commentary re-examines a recent article by Labonté et al on the recent changes to two relevant provisions relating to patent rights in the final version of the United-States-Mexico-Canada Agreement (USMCA). Although the USMCA’s final revised version does not add more pharmaceutical patent prote...

Descripción completa

Detalles Bibliográficos
Autor principal: Adekola, Tolulope Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275535/
https://www.ncbi.nlm.nih.gov/pubmed/32503571
http://dx.doi.org/10.1186/s12992-020-00579-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275535/
https://www.ncbi.nlm.nih.gov/pubmed/32503571
http://dx.doi.org/10.1186/s12992-020-00579-y

Ejemplares similares